These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

4211 related items for PubMed ID: 20232788

  • 1. Cardiovascular characteristics in Marfan syndrome and their relation to the genotype.
    De Backer J.
    Verh K Acad Geneeskd Belg; 2009; 71(6):335-71. PubMed ID: 20232788
    [Abstract] [Full Text] [Related]

  • 2.
    Adam MP, Feldman J, Mirzaa GM, Pagon RA, Wallace SE, Amemiya A, Dietz H.
    ; 1993. PubMed ID: 20301510
    [Abstract] [Full Text] [Related]

  • 3. Alport syndrome. Molecular genetic aspects.
    Hertz JM.
    Dan Med Bull; 2009 Aug; 56(3):105-52. PubMed ID: 19728970
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Prophylactic Oophorectomy: Reducing the U.S. Death Rate from Epithelial Ovarian Cancer. A Continuing Debate.
    Piver MS.
    Oncologist; 1996 Aug; 1(5):326-330. PubMed ID: 10388011
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. TGFBR1 and TGFBR2 mutations in patients with features of Marfan syndrome and Loeys-Dietz syndrome.
    Singh KK, Rommel K, Mishra A, Karck M, Haverich A, Schmidtke J, Arslan-Kirchner M.
    Hum Mutat; 2006 Aug; 27(8):770-7. PubMed ID: 16799921
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. [Prevalence of cardiovascular manifestations in Marfan syndrome].
    Porciani MC, Attanasio M, Lepri V, Lapini I, Demarchi G, Padeletti L, Pepe G, Abbate R, Gensini GF.
    Ital Heart J Suppl; 2004 Aug; 5(8):647-52. PubMed ID: 15554020
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Clinical management of the cardiovascular complications of the Marfan syndrome.
    Gerry JL, Morris L, Pyeritz RE.
    J La State Med Soc; 1991 Mar; 143(3):43-51. PubMed ID: 2026928
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. [Cardiovascular risk stratification. Systolic, diastolic or pulse pressure?].
    Pede S, Lombardo M.
    Ital Heart J Suppl; 2001 Apr; 2(4):356-8. PubMed ID: 19397006
    [Abstract] [Full Text] [Related]

  • 19. Ehlers-Danlos syndromes and Marfan syndrome.
    Callewaert B, Malfait F, Loeys B, De Paepe A.
    Best Pract Res Clin Rheumatol; 2008 Mar; 22(1):165-89. PubMed ID: 18328988
    [Abstract] [Full Text] [Related]

  • 20. Study of the impact of HIV genotypic drug resistance testing on therapy efficacy.
    Van Vaerenbergh K.
    Verh K Acad Geneeskd Belg; 2001 Mar; 63(5):447-73. PubMed ID: 11813503
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 211.